John M. Vierling

JOhn Vierling

Title: Physician, Educator
Company: Baylor College of Medicine
Location: Houston, Texas, United States

John M. Vierling, Physician and Educator at the Baylor College of Medicine, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in surgery, hepatology and higher education.

Celebrating over 40 years of experience as a practicing physician and educator, Dr. Vierling has dedicated his career to the study of the pathogenesis and the treatment of liver diseases, as well as their complications. Renowned for his contributions within the Baylor College of Medicine, he currently holds the positions of a professor of medicine, the chief of hepatology, the director of Baylor Liver Health, a professor of surgery and the director of Advanced Liver Therapies at St. Luke’s Medical Center. He initially obtained a Bachelor of Arts in biology with great distinction from Stanford University in 1967 before earning a Doctor of Medicine from Stanford University in 1972. Thereafter, he completed a residency at the University of Rochester Strong Memorial Hospital in 1974, a research fellowship at the National Institute of Health in 1977 and a fellowship at the University of California, San Francisco School of Medicine in 1978. Furthermore, he became board certified in internal medicine and gastroenterology.

From 2012 to 2018, Dr. Vierling found notable success as the principal of Clinical Research Centers of America LLC. Moreover, he excelled as the medical director of liver transplantation and the director of hepatology at the University of Colorado in Denver between 1979 and 1990, through which he is credited with establishing the institution’s liver transplant program. Throughout his career, he has garnered additional expertise through teaching appointments at the University of California at Los Angeles and directorship roles at Cedars-Sinai Medical Center in Los Angeles. Furthermore, he has served as a board director and on several committees on behalf of Athenex Inc., a global biopharmaceutical company, and the American Association for the Study of Liver Disease Foundation’s campaign committee. Moreover, he is recognized as a fellow of the American Gastroenterology Association and the American College of Physicians and is a past president of the American Association for the Study of Liver Diseases.

Researching and advocating toward the end of hepatobiliary diseases, Dr. Vierling has been especially interested in immunopathogenic mechanisms in injuries due to viral infection, autoimmunity and other medical conditions. In an effort to remain abreast with advancements in the field, he has maintained professional affiliations with organizations such as the Asian Pacific Association for the Story of the Liver, the International Association for the Study of Liver and the European Association for the Study of Liver. Additionally, he has authored and edited numerous scholarly articles, textbooks and journals and has served as a frequent speaker at national and international events. For his achievements, he is honored to have been presented with accolades such as the Distinguished Scientist Award from Saint Luke’s Hospital and the George Jamieson Award for Outstanding Public Service from the American Liver Foundation. Furthermore, he has been named to revered medical publications such as the Best Doctors in America and America’s Top Doctors via Castle Connolly and has been cited in approximately 15 editions of Who’s Who in America, Who’s Who in Medicine and Healthcare, Who’s Who in Science and Engineering, Who’s Who in the South and Southwest and Who’s Who in the West.

For more information, please visit:

Baylor College of Medicine

Research Gate

Contact Dr. Vierling: